Cargando…
Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse
Inflammatory bowel diseases (IBD) are characterized by a chronic and recurrent gastrointestinal condition, including mainly ulcerative colitis (UC) and Crohn’s disease (CD). Cannabis sativa (CS) is widely used for medicinal, recreational, and religious purposes. The most studied compound of CS is te...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215817/ https://www.ncbi.nlm.nih.gov/pubmed/32331305 http://dx.doi.org/10.3390/ijms21082940 |
_version_ | 1783532276220428288 |
---|---|
author | de Carvalho, Antonelly Cassio Alves de Souza, Gabriela Achete de Marqui, Samylla Vaz Guiguer, Élen Landgraf Araújo, Adriano Cressoni Rubira, Claudio José Goulart, Ricardo de Alvares Flato, Uri Adrian Prync Bueno, Patricia Cincotto dos Santos Buchaim, Rogério Leone Barbalho, Sandra M. |
author_facet | de Carvalho, Antonelly Cassio Alves de Souza, Gabriela Achete de Marqui, Samylla Vaz Guiguer, Élen Landgraf Araújo, Adriano Cressoni Rubira, Claudio José Goulart, Ricardo de Alvares Flato, Uri Adrian Prync Bueno, Patricia Cincotto dos Santos Buchaim, Rogério Leone Barbalho, Sandra M. |
author_sort | de Carvalho, Antonelly Cassio Alves |
collection | PubMed |
description | Inflammatory bowel diseases (IBD) are characterized by a chronic and recurrent gastrointestinal condition, including mainly ulcerative colitis (UC) and Crohn’s disease (CD). Cannabis sativa (CS) is widely used for medicinal, recreational, and religious purposes. The most studied compound of CS is tetrahydrocannabinol (THC) and cannabidiol (CBD). Besides many relevant therapeutic roles such as anti-inflammatory and antioxidant properties, there is still much controversy about the consumption of this plant since the misuse can lead to serious health problems. Because of these reasons, the aim of this review is to investigate the effects of CS on the treatment of UC and CD. The literature search was performed in PubMed/Medline, PMC, EMBASE, and Cochrane databases. The use of CS leads to the improvement of UC and CD scores and quality of life. The medical use of CS is on the rise. Although the literature shows relevant antioxidant and anti-inflammatory effects that could improve UC and CD scores, it is still not possible to establish a treatment criterion since the studies have no standardization regarding the variety and part of the plant that is used, route of administration and doses. Therefore, we suggest caution in the use of CS in the therapeutic approach of IBD until clinical trials with standardization and a relevant number of patients are performed. |
format | Online Article Text |
id | pubmed-7215817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-72158172020-05-22 Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse de Carvalho, Antonelly Cassio Alves de Souza, Gabriela Achete de Marqui, Samylla Vaz Guiguer, Élen Landgraf Araújo, Adriano Cressoni Rubira, Claudio José Goulart, Ricardo de Alvares Flato, Uri Adrian Prync Bueno, Patricia Cincotto dos Santos Buchaim, Rogério Leone Barbalho, Sandra M. Int J Mol Sci Review Inflammatory bowel diseases (IBD) are characterized by a chronic and recurrent gastrointestinal condition, including mainly ulcerative colitis (UC) and Crohn’s disease (CD). Cannabis sativa (CS) is widely used for medicinal, recreational, and religious purposes. The most studied compound of CS is tetrahydrocannabinol (THC) and cannabidiol (CBD). Besides many relevant therapeutic roles such as anti-inflammatory and antioxidant properties, there is still much controversy about the consumption of this plant since the misuse can lead to serious health problems. Because of these reasons, the aim of this review is to investigate the effects of CS on the treatment of UC and CD. The literature search was performed in PubMed/Medline, PMC, EMBASE, and Cochrane databases. The use of CS leads to the improvement of UC and CD scores and quality of life. The medical use of CS is on the rise. Although the literature shows relevant antioxidant and anti-inflammatory effects that could improve UC and CD scores, it is still not possible to establish a treatment criterion since the studies have no standardization regarding the variety and part of the plant that is used, route of administration and doses. Therefore, we suggest caution in the use of CS in the therapeutic approach of IBD until clinical trials with standardization and a relevant number of patients are performed. MDPI 2020-04-22 /pmc/articles/PMC7215817/ /pubmed/32331305 http://dx.doi.org/10.3390/ijms21082940 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review de Carvalho, Antonelly Cassio Alves de Souza, Gabriela Achete de Marqui, Samylla Vaz Guiguer, Élen Landgraf Araújo, Adriano Cressoni Rubira, Claudio José Goulart, Ricardo de Alvares Flato, Uri Adrian Prync Bueno, Patricia Cincotto dos Santos Buchaim, Rogério Leone Barbalho, Sandra M. Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse |
title | Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse |
title_full | Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse |
title_fullStr | Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse |
title_full_unstemmed | Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse |
title_short | Cannabis and Canabidinoids on the Inflammatory Bowel Diseases: Going Beyond Misuse |
title_sort | cannabis and canabidinoids on the inflammatory bowel diseases: going beyond misuse |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7215817/ https://www.ncbi.nlm.nih.gov/pubmed/32331305 http://dx.doi.org/10.3390/ijms21082940 |
work_keys_str_mv | AT decarvalhoantonellycassioalves cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse AT desouzagabrielaachete cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse AT demarquisamyllavaz cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse AT guiguerelenlandgraf cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse AT araujoadrianocressoni cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse AT rubiraclaudiojose cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse AT goulartricardodealvares cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse AT flatouriadrianprync cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse AT buenopatriciacincottodossantos cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse AT buchaimrogerioleone cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse AT barbalhosandram cannabisandcanabidinoidsontheinflammatoryboweldiseasesgoingbeyondmisuse |